Sopheon announces that the Company has granted 36,650 options over ordinary shares of 20 pence each in the share capital of the Company (“Options”) to certain directors. These grants are part of a wider option grant of 163,900 Options, to certain key executives and departmental managers of the Company. Of the directors, Andrew Michuda has been granted 25,000 Options, and Arif Karimjee has been granted 11,650 Options.

The Options granted will vest over 3 years, and are exercisable up to 10 years from the date of grant. The exercise price of the Options is 467.5 pence per share, being the mid-market closing price on AIM on 15 February 2017.

Following this grant, Andrew Michuda has 240,000 Options in total, and Arif Karimjee has 75,000 Options. In addition, Andrew Michuda and Arif Karimjee respectively own 30,000 and 50,000 ordinary shares of the Company, and they (or persons connected with them) are respectively invested in £45,000 and £27,000 of the Company’s convertible loan stock.

For Further Information Contact:

Barry Mence, Chairman
Arif Karimjee, CFO
Sopheon plc + 44 (0) 1276 919 560
Carl Holmes / Giles Rolls (corporate finance)
Mia Gardener (corporate broking)
finnCap + 44 (0) 20 7220 0500

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.


Print Friendly, PDF & Email